Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,557 | -11,911 | -14,850 | -14,145 | -12,386 |
| Depreciation Amortization | 69 | 68 | 58 | 45 | 15 |
| Accounts payable and accrued liabilities | -130 | 129 | -711 | 841 | -272 |
| Other Working Capital | -670 | 635 | -1,768 | 1,594 | -937 |
| Other Operating Activity | 2,518 | 2,842 | 5,037 | 2,612 | 4,031 |
| Operating Cash Flow | $-4,770 | $-8,237 | $-12,234 | $-9,053 | $-9,549 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 2,101 | -2,091 | 3 | 1,252 |
| PPE Investments | N/A | N/A | -75 | -195 | -80 |
| Investing Cash Flow | $N/A | $2,101 | $-2,166 | $-192 | $1,172 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,098 | N/A | N/A | N/A | 379 |
| Other Financing Activity | 0 | 0 | -284 | -46 | 0 |
| Financing Cash Flow | $14,098 | $N/A | $-284 | $-46 | $379 |
| Beginning Cash Position | 10,479 | 16,615 | 31,299 | 40,590 | 48,588 |
| End Cash Position | 19,807 | 10,479 | 16,615 | 31,299 | 40,590 |
| Net Cash Flow | $9,328 | $-6,136 | $-14,684 | $-9,291 | $-7,998 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,770 | -8,237 | -12,234 | -9,053 | -9,549 |
| Capital Expenditure | N/A | N/A | -75 | -195 | -80 |
| Free Cash Flow | -4,770 | -8,237 | -12,309 | -9,248 | -9,629 |